![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 25, 22662-22669, June 21, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
¶
From the Departments of
Microbiology and
Immunology and § Biochemistry and Biophysics, University
of Rochester Medical Center, Rochester, New York 14642
Received for publication, January 8, 2002, and in revised form, March 28, 2002
| |
ABSTRACT |
|---|
|
|
|---|
It has previously been reported that mutations in
the Gln151 residue of human immunodeficiency virus
type 1 (HIV-1) reverse transcriptase (RT) greatly enhance RT
fidelity. In this study, we employed pre-steady state
kinetic assays to elucidate the mechanistic role of residue Gln151 in highly error prone DNA synthesis by HIV-1 RT.
Using our Q151N high fidelity mutant, which is structurally altered in
its ability to interact with the 3'-OH on the sugar moiety of the
incoming deoxynucleotide triphosphate (dNTP), we examined how this
change in RT-dNTP interaction affects HIV-1 RT fidelity. First, we
found the binding affinity (KD) of wild type and
Q151N RT proteins to different template/primers to be similar. These
results indicate that the Gln151 residue is not
involved in the formation of the binary complex (RT·template/primer)
during DNA polymerization. We also found that by changing residue 151 from a Gln It is becoming more apparent that many organisms employ
multiple DNA polymerases to replicate their genomes. Some of these DNA
polymerases are specifically involved in error prone DNA synthesis required for either spontaneous mutagenesis or bypassing DNA damage (1-3). Recent biochemical studies of DNA polymerases Human immunodeficiency virus type 1 (HIV-1) has a single DNA polymerase
called reverse transcriptase (RT). HIV-1 RT is one of the most error
prone DNA polymerases involved in DNA replication (8-10). This low
replication fidelity of HIV-1 RT and the resultant error prone DNA
synthesis are a presumptive source of HIV-1 genomic hypervariation (9,
10). Although HIV-1 RT must efficiently synthesize DNA during viral
genomic replication, it concomitantly produces genomic mutations in
order to evolve and escape host immune selection. In contrast to
organisms that employ multiple polymerases for the activities of
genomic replication and mutagenesis, HIV-1 RT has been adapted to
execute both of these functions. The fact that HIV-1 RT is able to
resolve the kinetic issues associated with efficient but error prone
DNA synthesis makes it a unique model to study in understanding the
mechanistic and structural elements involved in replication fidelity.
DNA polymerization is an ordered reaction that consists of a series of
sequential steps. First the polymerase must bind T/P to form a binary
polymerase·T/P complex. Binding of the dNTP follows and the ternary
polymerase·T/P·dNTP complex then undergoes conformational change
and catalysis (7, 11). Pre-steady state kinetics examines the ability
of the polymerase to bind and then incorporate dNTP. Using a rapid
quench instrument, one can measure 1) the binding of dNTPs to the DNA
polymerase (Kd) and 2) the maximum rate of dNTP
incorporation (kpol) (7, 11). Incorporation of
incorrect dNTPs under pre-steady state conditions has been studied in
order to understand the nature of mutation synthesis by DNA polymerases
(12-14). These types of studies examining wild type HIV-1 RT fidelity
demonstrate that HIV-1 RT differentiates between correct and incorrect
dNTPs in both the binding (Kd) and incorporation
(kpol) steps by 250-fold and 9-80-fold,
respectively (15). This suggests that events that occur during both
dNTP binding and dNTP incorporation affect the accuracy of DNA
synthesis by HIV-1 RT.
Studies involving mutants with altered fidelity have been invaluable in
delineating the structural and biochemical determinants of replication
accuracy. Examples are the pre-steady state kinetic studies performed
with the Klenow fragment from Escherichia coli DNA
polymerase I (14, 16). Structural analyses of Klenow fragment and
results from random mutagenesis of Taq polymerase illustrate that interactions between the incoming dNTP and the dNTP binding domain, called the O helix, are important molecular determinants in
overall polymerase fidelity (17-20). Like these studies, our analysis
of high fidelity HIV-1 RT mutants will elucidate the mechanistic and
structural role of wild type residues during DNA polymerization and
mutation synthesis.
Recently, we reported that the Q151N mutant has 12.5 times higher
fidelity than wild type HIV-1 RT based on the M13 lacZ Interestingly, the Q151N mutation, like the Q151M viral mutation, has
increased resistance to nucleoside RT inhibitors such as
azidothymidine (23, 24). This finding suggests that the wild
type Gln151 residue may interact with the azido group of
the incoming AZTTP, assisting in the AZTTP incorporation reaction.
Presumably, the Q151N and Q151M mutations might prevent binding of
AZTTP to the active site of HIV-1 RT, conferring AZTTP
resistance (21, 22). However, unlike the Q151N mutant, the fidelity of
Q151M is the same as that of wild type HIV-1 RT (22). Even though Q151M
has evolved a mechanism to discriminate against AZTTP, it is still able
to bind incorrect dNTPs like wild type RT.
In this study, we investigated the mechanistic steps of DNA
polymerization specifically affected by the Q151N HIV-1 RT high fidelity mutation. Specifically, we decided to examine the kinetics of
DNA polymerization from an RNA template, which is an activity unique to
reverse transcriptases. To do this we employed pre-steady state kinetic
assays to identify alterations in dNTP binding or dNTP incorporation.
We also used a double filter dot blot assay to assess changes in RT
binding to the T/P. Our study reveals that residue Gln151
is a molecular element in HIV-1 RT infidelity. The role of residue Gln151 is to promote mutation synthesis by increasing RT
binding to incorrect dNTPs.
Chemicals and HIV-1 RT Proteins--
N-terminal end His
tagged wild type and Q151N HIV-1 RT proteins were purified as
previously described (21, 25). With our protocol, we were able to
purify 2 mg of RT proteins with >95% purity from a 1-liter culture.
All dNTPs were purchased from Amersham Biosciences. DNA
oligonucleotides were purchased from Invitrogen, and RNA template was
synthesized by Dharmacon. Primers were labeled with
[ Pre-steady State Kinetic Assay--
Pre-steady state burst and
single turnover experiments were employed to examine the transient
kinetics associated with a single nucleotide incorporating
onto the 3' end of a 32P-labeled 17-mer A primer
(5'-CGCGCCGAATTCCCGCT-3') annealed to a 40-mer RNA template
(5'-AAGCUUGGCUGCAGAAUAUUGCUAGCGGGAAUUCGGCGCG-3') (11, 15). For
both sets of reactions, we used 20 µl of T/P preincubated with
purified HIV-1 RT protein and reaction buffer (25 mM
Tris-HCl, pH 8.0, 40 mM KCl, 2 mM
dithiothreitol, 5 mM MgCl2, and 0.1 mg/ml
bovine serum albumin). This mixture was injected into one sample tube
of the rapid quench machine (Kintek). An equal volume of dNTP
preincubated with Mg2+ (10 mM) was injected
into the other sample tube. The polymerization reaction was initiated
by rapidly mixing the two reactants and terminated by adding 0.25 M EDTA at different time points.
In the pre-steady state burst experiments, T/P (150 nM) was
present in excess of RT (~50 nM) and the reaction was
initiated by the addition of 400 µM dNTP. These
experiments were used to determine the active site concentrations of
the RT proteins (see data analysis; Refs. 7 and 11). The pre-steady
state single turnover experiments were used to determine the dNTP
concentration dependence of the purified HIV-1 RT proteins. In the
presence of varying dNTP concentrations (in the range of 600 nM to 2.5 mM), RT (100 nM) was used
in slight excess of T/P (90 nM). In reactions involving
incorrect dNTPs, the experiments were performed manually at longer
periods of time and used a higher concentration of RT (700 nM) (15, 26).
Product Analysis--
The reactions were analyzed by 14%
denaturing sequencing gel electrophoresis. The extended product in each
reaction was quantified with the Cyclone phosphorimager (PerkinElmer
Life Sciences).
Data Analysis--
Pre-steady state kinetic data were analyzed
using nonlinear regression. Equations were generated with the
KaleidaGraph program, version 3.51 (Synergy Software). Data points
obtained during the burst experiment were fitted to the burst
equation shown below (7, 11).
Double Filter Dot Blot Assay for KD--
We employed
a standard assay protocol previously established to determine the
KD of wild type and mutant RTs on three different
T/Ps: 17-mer/40-mer RNA template, 17-mer/18-mer DNA template, and
18-mer/18-mer blunt end T/P. A protein binding filter (top filter,
nitrocellulose; Schleicher & Schuell), nucleic acid binding filter
(bottom filter, DEAE; Schleicher & Schuell), and dot blot system
(Schleicher & Schuell) were prepared as described (27, 28). RT proteins
(50 nM active site concentration) were incubated with
different concentrations (10-800 nM, 20 µl) of 5'
32P-labeled T/Ps at 37 °C for 3 min. The RT and T/P
mixtures were applied to each well of the dot blot system and washed
twice with 100 µl of reaction buffer. After drying both filters, the
filters were analyzed using a phosphorimager, and the percentage
binding at each T/P concentration was quantitated. The data were then fitted to the binding curve equation previously described (see Eq. 3
below; Ref. 28).
Initial Burst and Active Site Concentration of HIV-1 RT
Proteins--
We determined the active site concentrations of the wild
type and Q151N HIV-1 RT proteins (Fig.
1). For this, the single nucleotide (dATP) incorporation reaction was performed using a T/P concentration in molar excess over the enzyme concentration. We observed both single
turnover events associated with the pre-steady state burst and multiple
rounds of DNA polymerization occurring during steady state kinetics.
Reactions ranging from 5 ms to 2 s were performed using the rapid
quench machine.
From Eq. 1, we can determine the active site concentration, the rate of
dNTP incorporation under pre-steady state conditions (kobs), and the rate of dNTP incorporation
during the steady state (kss) for both the wild
type and Q151N RT proteins at 400 µM dATP. In these
initial burst experiments, we used 100 nM wild type and 200 nM Q151N protein. Our results indicate that only 63 nM (63%) wild type RT and 46 nM (23%) Q151N
were actually active (Fig. 1). For the wild type RT,
kobs was 17.3 × 10 Pre-steady State Incorporation of Correct dATP by HIV-1 RT
Proteins--
Next, we determined the binding affinity
(Kd) of both the wild type and Q151N mutant HIV-1 RT
proteins for correct dATP on our T/P (Table
I). Concurrently, we measured the maximum rate at which wild type and mutant RTs incorporated correct dATP (kpol). By analyzing the dependence of reaction
rate (kobs) on dNTP concentration (Fig.
2), we are able to calculate
Kd and kpol (Eq. 2). Our wild
type HIV-1 RT pre-steady state kinetic values when wild type is using
dATP are similar to those previously published with dCTP as the correct
dNTP (12, 15). When we examined the Q151N protein, we observed a
120-fold decrease in binding affinity (increase in
Kd) compared to wild type HIV-1 RT, whereas we found
only a slight increase (1.6-fold) in the maximum rate of correct dNTP
incorporation (kpol; Table I). This suggests
that the Q151N mutation specifically reduces the initial binding
affinity of RT for the incoming correct dATP. A consequence of this
reduction in initial binding affinity (increase in
Kd) for dATP is a 75-fold reduction in the
pre-steady state incorporation efficiency
(kpol/Kd) of Q151N relative to wild type RT (Table I). It is apparent that the rate of correct dATP
incorporation for the Q151N mutant differs with dNTP concentration. Compared to wild type RT, which maximally incorporates correct dATP
(kpol) at 25 µM, the rate of dATP
incorporation (kpol) for the Q151N mutant at 25 µM is much less that that of wild type (Fig. 2). It is
possible that at low dNTP concentrations, the step of DNA
polymerization involving the Gln151 residue, likely initial
dNTP binding, becomes rate limiting. At high correct dATP
concentration, initial dNTP binding is not the rate-limiting step.
Q151N actually has a faster rate of dNTP incorporation than wild type
RT (kobs in Fig. 1 and
kpol in Fig. 2).
Pre-steady State Incorporation of Incorrect dNTPs by HIV-1 RT
Proteins--
Next, we measured the kinetic parameters associated with
the incorporation of the three incorrect dNTPs (dGTP, dCTP, and TTP) (Table I). Since incorporation of incorrect dNTPs is very slow and
inefficient, we performed the reactions manually and at high concentrations of RT protein and incorrect dNTP (see "Materials and
Methods" and Ref. 12). Analysis of the Q151N mutant is complicated because the Q151N reaction rate (kobs)
increases in a linear fashion with up to 2.5 mM incorrect
dNTPs. Although saturating concentrations of dNTP are >2.5
mM, higher dNTP concentrations (>2.5 mM)
cannot be used because they inhibit RT activity (reducing
kobs; Ref. 13). Because of this technical
difficulty, we could only estimate minimum kpol
values for Q151N (i.e. kobs at 2.5 mM incorrect dNTP). Additionally, we can conclude that the
Kd for Q151N with all incorrect dNTPs is apparently
higher than 2.5 mM.
In the scenario with incorrect dGTP, the binding affinity of wild type
HIV-1 RT is at least 75-fold lower than its binding affinity for
correct dATP (increase in Kd; Table I). The maximum
rate at which wild type RT incorporates incorrect dGTP is 4 × 105 times slower than when it incorporates correct dATP
(kpol). Similar changes in Kd
and kpol for wild type HIV-1 RT have also been
observed in previous experiments using correct dCTP and incorrect dNTPs
(12, 15). The efficiency of incorrect dGTP incorporation (kpol/Kd) by wild type RT on
our T/P, also termed misincorporation efficiency, was 4.4 × 10
Experimentally, we cannot obtain a true value for Q151N
misincorporation efficiency
(kpol/Kd). The values for
kpol and Kd are determined by
assessing the dependence of reaction rate on dNTP concentration (Eq. 2). However, Q151N incorporation of incorrect dNTPs at every dNTP
concentration tested was very low. The reaction rates with incorrect
dNTPs (up to 2.5 mM) were linear with respect to dNTP
concentration (data not shown), and as such, we cannot measure the
values of kpol and Kd for
Q151N. In the case of incorrect dGTP (Table I), if we estimate the
kpol of the mutant RT to be similar to that of
wild type RT and the Kd of the mutant to be higher
than 2.5 mM (Table I), then the misincorporation frequency
should be an order of magnitude lower than that of wild type RT. For
incorrect dCTP the Kd value is likely so high that
the misincorporation efficiency of Q151N is lower than wild type RT.
Further supporting the high fidelity nature of Q151N, incorrect TTP
incorporation was negligible at our sensitivity of measurement
(Fig. 3).
Keeping in mind that the actual Q151N misincorporation efficiency is
likely even lower than our estimated value, we see that these
differences are translated into a diminished rate of misincorporation by Q151N during steady state DNA synthesis. In the M13 lacZ
When using incorrect dCTP, wild type HIV-1 RT has at least a 150-fold
lower binding affinity (higher Kd) and a 3 × 105-fold slower rate of dNTP incorporation
(kpol) than when using correct dATP (Table I).
When we examine Q151N incorrect dCTP pre-steady state kinetic
parameters, we observe a minimum 7-fold decrease in binding affinity
(Kd) and a 7-fold increase in maximum rate of dNTP
incorporation (kpol) as compared to wild type.
It is clear that residue Gln151 has a role in the initial
binding step of HIV-1 RT to incorrect dNTPs. Because diminished binding
to incorrect dCTP is somewhat offset by the increased rate at which the
Q151N mutant incorporates incorrect dCTP, the misincorporation
efficiency of Q151N for incorrect dCTP is similar to that seen in wild
type HIV-1 RT (3.0-3.1 × 10
Data for the last incorrect dNTP, TTP, could not be obtained. As shown
in Fig. 3, even at the highest TTP concentration (2.5 mM)
and the longest incubation time (10 min) there was no detectable extension of incorrect TTP by the Q151N mutant. This suggests that the
Q151N misincorporation efficiency for TTP must be extremely low, which
corresponds with the high fidelity nature of the Q151N mutant.
Binding Constants of RT Proteins to T/Ps--
We also tested
whether the Q151N mutation affects RT binding to T/P (Table
II). For this we determined the binding
affinity of wild type and Q151N RT proteins to three different T/Ps: 1) the 18-mer/40-mer RNA T/P used in our pre-steady state experiments, 2)
a 17-mer/18-mer DNA T/P, and 3) an 18-bp blunt end DNA T/P, as measured
by the double filter dot blot assay (27, 28). Binding curves and
binding constants of the RT proteins were obtained using the same
active site concentrations as determined in the pre-steady state
kinetic assay described previously. In this experiment, we found that
the wild type and Q151N RT proteins have very similar binding affinity
to all three T/Ps (Table II). However, the KDs of
these two proteins to the blunt end T/P are higher than those to the
18-mer/40-mer RNA T/P. This indicates that both the wild type and Q151N
RT proteins bind a 3' recessed T/P better than a blunt ended T/P. These
findings support the likelihood that residue Gln151 is not
involved in the DNA polymerization step of RT binding to T/P
(i.e. formation of the RT·T/P binary complex).
Pre-steady state kinetic studies have shown that the ability of
DNA polymerases to distinguish between correct and incorrect dNTPs
affects the efficiency of DNA polymerization (7). More specifically,
binding and incorporating incorrect dNTPs are inhibitory to DNA
synthesis. HIV-1 RT is a viral polymerase that executes the tasks of
viral mutagenesis and genomic replication. It is able to incorporate
incorrect nucleotides so as to introduce mutations into the viral
genome, but it also readily incorporates correct nucleotides to
efficiently synthesize DNA. The fact that HIV-1 RT simultaneously
performs both these functions makes it a unique model to examine for
understanding the mechanistic and structural elements involved in
replication fidelity. Our study suggests that HIV-1 RT has evolved
residue Gln151 as a mechanism to resolve this kinetic issue.
We and others have demonstrated that mutations in the
Gln151 residue increase HIV-1 RT fidelity as measured by
steady state fidelity assays (21, 22). Structural modeling suggests
that the Gln151 residue of HIV-1 RT directly interacts with
the 3'-OH on the sugar moiety of the incoming dNTP (21, 29). Since
residue 151 interacts with the incoming dNTP, it is likely that changes in the steps of DNA polymerization involving RT-dNTP interactions account for the increased fidelity in the Q151N HIV-1 RT mutant. To
identify mechanistic steps affected by the Q151N HIV-1 RT high fidelity
mutation, we employed pre-steady state kinetic assays that specifically
examine the steps of dNTP binding and dNTP incorporation (7). By
comparing the pre-steady state kinetic parameters of the wild type and
Q151N HIV-1 RT proteins, we found that residue Gln151 may
contribute to HIV-1 RT infidelity by improving RT binding to incorrect
dNTPs. Our filter binding assay results also substantiated the idea
that Gln151 is specifically important for RT interaction
with the incoming dNTP. We measured the binding affinity
(KD) of the wild type and mutant RT proteins to
three different types of T/P and found that the Q151N mutation does not
affect RT-T/P binding.
Binding affinity as a mechanism of fidelity is founded on the premise
that there exists a difference in polymerase binding to correct and
incorrect dNTPs. For example, the initial binding affinities
(Kd) of the E. coli Klenow fragment to
correct and incorrect dNTPs are similar. As such, the polymerase is not able to distinguish between correct and incorrect dNTPs. In the Klenow
fragment, initial dNTP binding is not a mechanistic determinant of
fidelity (14, 16). In contrast, initial binding of the T7 DNA
polymerase to dNTPs does contribute to its low misincorporation efficiency. The binding affinity of the T7 DNA polymerase for incorrect
dNTP is much lower than that for correct dNTP (30). Like the T7 DNA
polymerase, HIV-1 RT differs in its ability to bind correct and
incorrect dNTPs (Table I; Ref. 15); however, the difference is that
HIV-1 RT (micromolar Kd) binds incorrect dNTPs
better than the T7 DNA polymerase (millimolar Kd;
Ref. 30). As a result, HIV-1 RT has lower fidelity than the T7 DNA polymerase.
When residue 151 is altered from a Gln Not surprisingly, since structural data of HIV-1 RT complexed with T/P
and TTP show that the side chain of residue 151 interacts with the
3'-OH on the sugar moiety of correct TTP, we also observe a change in
Q151N binding affinity for correct dNTP (29). Under pre-steady state
conditions, binding of the Q151N RT to correct dATP is dramatically
reduced (120-fold increase in Kd). Like binding to
incorrect dNTPs, the dramatic reduction in binding affinity (increase
in Kd) observed in the Q151N mutant suggests that
wild type residue Gln151 is a major determinant for correct
dNTP binding. Although binding of Q151N to correct dNTP is diminished,
we must keep in mind the magnitude of this change. Whereas we estimate
that the Kd for incorrect dNTPs is a minimum of 2.5 mM, the Kd for Q151N with correct dATP
on our T/P is 293 µM. In actuality, Q151N binds incorrect
dNTPs much less efficiently than it binds correct dNTPs.
As mentioned earlier, efficient enzymatic DNA polymerase activity
requires efficient discrimination between correct and incorrect dNTPs.
Tight binding to incorrect dNTPs or poor discrimination against
incorrect dNTPs may actually reduce the efficiency of DNA
polymerization (7, 13). Even though wild type residue Gln151 may bind incorrect dNTPs and promote highly error
prone DNA synthesis, a consequence could be inefficient viral
replication. On the other hand, HIV-1 RT is still able to discriminate
between correct and incorrect dNTPs because of the large difference in
Gln151 binding affinity for these nucleotides. This
relatively large binding difference between correct and incorrect dNTPs
is likely a key element that maintains the balance between highly error prone DNA polymerization and highly efficient viral replication by
HIV-1 RT.
The kinetic fidelity of a DNA polymerase is usually measured by the
ratio of kpol/Kd between
incorrect and correct dNTPs. This defines the actual capability of the
polymerase to discriminate between correct and incorrect dNTPs during
DNA polymerization (12, 15). In this study, we could not determine the
actual discrimination efficiency of the Q151N mutant because the
binding affinity (Kd) of the mutant for incorrect
dNTP could not be experimentally determined. We were able to make a
high end estimate for the efficiency of incorrect dGTP incorporation (kpol/Kd), or the
misincorporation efficiency of dGTP. If we compare the misincorporation
efficiency of incorrect dGTP (kpol/Kd) between wild type
and mutant RT, we see that the Q151N mutant is at least 6-fold less
efficient at incorporating incorrect dGTP than wild type RT. Since
Q151N is diminished in its ability to bind dCTP and TTP, it is likely
that Q151N is also less efficient at misincorporating these
nucleotides. Interestingly, a reduction in the error rate of the Q151N
mutant was also observed in steady state fidelity assays (21, 22). It
is possible that reduction in RT binding to incorrect dNTPs affects
both the pre-steady state rate of misincorporation and the overall
steady state rate of mutation synthesis.
The structure of a transient HIV-1 RT ternary complex with an incorrect
dNTP (RT·incorrect dNTP·T/P) is not currently available. To better
understand the mechanism of residue Gln151 in RT fidelity,
we previously generated a working model based on structural data of
HIV-1 RT complexed with a dNTP (29). As seen in Fig.
4, correct positioning of the incoming
TTP (black) in the dNTP binding pocket of HIV-1 RT is likely
engineered by various interactions between the dNTP binding residues
and the incoming dNTP. Wild type Gln151 residue
(light green) is positioned such that it makes a nonspecific interaction with the 3'-OH on the ribose of the incoming TTP. The
nearby Arg73 residue (gray) assists in
Gln151 binding with the incoming TTP by stabilizing the
placement of Gln151 in the active site. It is possible that
improper base-pairing between the template nucleotide
(blue-green) and the incoming incorrect dNTP distorts the
geometric orientation of the incorrect dNTP in the RT active site. If
the side chain of the wild type Gln151 residue is flexible
enough, the interaction between the Gln151 residue and the
3'-OH of the incoming incorrect dNTP may still be made, as suggested by
the low Kd (micromolar range) of wild type to
incorrect dNTPs. This interaction alone may be able to secure binding
of the incorrect dNTP to the dNTP binding pocket, allowing the open
ternary complex (RT·dNTP·T/P) to undergo conformational change and
catalysis. In contrast, when the Q151N mutant (orange)
incorporates incorrect dNTPs, there is an absence in 1) interaction
between RT and the incoming incorrect dNTP and 2) base-pairing between
the template nucleotide and the incoming incorrect dNTP. Incorrect
dNTPs may not stably bind to the dNTP binding pocket of the Q151N RT,
which would account for the extremely high Kd
(unmeasurable micromolar range) of Q151N to incorrect dNTPs.
Consequently, HIV-1 RT fidelity would increase.
Asn, the maximum rate of dNTP incorporation
(kpol) for both correct and incorrect dNTPs was
not affected. In contrast, the ability of the Q151N mutant to bind both
correct and incorrect dNTPs (Kd) was
diminished. The Q151N mutant was 120-fold less efficient at binding
correct dNTP than wild type RT, and its decrease in binding was such
that we were unable to measure the actual binding affinity of Q151N for
incorrect dNTPs. Presumably, the fidelity increase observed during the
steady state is explained by this defect in Q151N binding to incorrect
dNTP. In wild type RT, residue Gln151 is important for
tight binding of incorrect dNTPs and may contribute to the low fidelity
nature of HIV-1 RT. Since the Q151N mutation also alters RT binding to
correct dNTPs, the wild type Gln151 residue may play an
important role in efficient binding of RT to correct dNTPs. Our
findings suggest that residue Gln151 is an important
element for the execution of both highly error prone and efficient DNA
synthesis by HIV-1 RT.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
and
and
their bacterial UmuC/DinB homologs (4-6) show that these are actually
very low fidelity polymerases. It is possible that these organisms have
evolved functionally diverse DNA polymerases for the different
activities of genomic replication and mutagenesis. As demonstrated in a
series of kinetic experiments with various DNA polymerases, it is clear
that the ability to incorporate incorrect dNTPs1 affects the efficiency
of DNA synthesis (7). In other words, low fidelity and poor ability to
discriminate between correct and incorrect dNTPs are detrimental to
efficient DNA polymerization, which is likely essential for chromosomal
DNA replication. The fact that efficient DNA synthesis and error prone
DNA synthesis are kinetically at odds with one another may explain why
possession of separate DNA polymerases specific for either replication
or mutagenesis is beneficial.
forward
mutation assay (21). Data from single nucleotide steady state kinetic
assays using the Q151N mutant also substantiated our findings (22).
Structural examination showed that the wild type Gln151
residue interacts with the 3'-OH on the sugar moiety of the incoming dNTP (21). It has been suggested that this interaction between the
Gln151 residue and the 3'-OH of the incorrect dNTP
stabilizes RT binding to the incorrect dNTP. This would allow for
chemical DNA polymerization to occur even in the absence of
base-pairing between the incoming incorrect dNTP and the template
nucleotide. When residue 151 is altered from a Gln
Asn, there is a
loss in the interaction of Gln151 with the incoming
incorrect dNTP as well as in the base-pairing between the template
nucleotide and the incorrect dNTP. Failure of stable binding precludes
incorporation of the incorrect dNTP and results in an increase in RT fidelity.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-32P]ATP (Amersham Biosciences) and T4 nucleotide
kinase (New England BioLabs).
The value A is the amplitude of the burst, which
reflects the actual concentration of enzyme that is in active form.
kobs is the observed first-order rate constant
for dNTP incorporation, whereas kss is the
observed steady state rate constant (11, 15, 26). Data from
single-turnover experiments were fit to a single exponential equation
that measures the rate of dNTP incorporation (kobs) per given dNTP concentration ([dNTP]).
These results can then be used to determine Kd, the
dissociation constant for dNTP binding to the RT·T/P binary complex.
This was done by fitting the data to the following hyperbolic
equation.
(Eq. 1)
From this equation, we could then identify the kinetic constants
for each RT during pre-steady state kinetics:
kpol is the maximum rate of dNTP incorporation,
and Kd is equilibrium dissociation constant for the
interaction of dNTP with the E·DNA complex (11, 12).
(Eq. 2)
(Eq. 3)
The variables RT-T/P, KD, RTt,
and T/P reflect productive RT-template concentration, equilibrium
dissociation constant for RT binding to T/P, active RT concentration
(see Fig. 1), and total T/P concentration, respectively. From Eq. 3,
the KD values of wild type and mutant RTs to these
three T/Ps were determined (28).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (10K):
[in a new window]
Fig. 1.
Pre-steady state and steady state kinetics of
HIV-1 RT wild type and Q151N proteins. Pre-steady state kinetics
of incorporation of dATP with wild type (A) and Q151N
(B) HIV-1 RT proteins. Pre-steady state kinetics of
incorporation of dAMP onto a 32P-labeled 17-mer primer
annealed to the 40-mer RNA template by wild type and Q151N HIV-1 RTs
were measured. Reactions were initiated by mixing a preincubated
solution of RT and T/P (150 nM) with dATP (400 µM) and Mg2+ (10 mM) under rapid
quench conditions. The reactions were quenched at the indicated time (5 ms to 2 s) and analyzed by 14% denaturing gel. The RT·T/P
concentrations that were equal to the burst heights, indicating active
site concentrations, were determined by extrapolation to the
y axis (7, 12). The solid line represents the
best fit of the data to a burst equation with an amplitude A
(active site concentration) = 63 ± 4 nM (wild
type), and 46 ± 5 nM (Q151N). The observed
first-order rate constant for the burst phase
kobs = 17.3 × 10
3 ± 2 × 10
3 ms
1 (wild type) and 9.0 × 10
3 ± 2 × 10
3 ms
1
(Q151N), and the observed rate constant for the linear phase
kss = 0.09 × 10
3 ± 0.05 × 10
3 ms
1 (wild type) and
0.6 × 10
3 ± 0.1 × 10
3
ms
1 (Q151N).
3
ms
1, and kss was 0.09 × 10
3 ms
1. For the Q151N protein, the values
for kobs and kss were
9.0 × 10
3 and 0.6 × 10
3
ms
1, respectively (Fig. 1). These differences in
kobs and kss suggest that
reaction rates for both proteins are faster under pre-steady state
kinetic conditions (kobs) than steady state
kinetic conditions (kss), which has been
previously demonstrated (7, 15). Presumably, the lower rate in the
steady state is due to the fact that in this time scale, reactions
include multiple rounds of dNTP incorporation and involve various
complex steps that may be rate determining (i.e. T/P binding
and product release). Surprisingly, the steady state rate of catalysis
(kss) for the Q151N protein is 6-fold higher
than that of wild type RT. It is possible that the Q151N mutation may
overcome kinetic barriers that restrict wild type DNA polymerization
during the steady state.
Pre-steady state kinetic parameters of HIV-1 RT wild type and Q151N
proteins

View larger version (9K):
[in a new window]
Fig. 2.
dATP dependence of wild type and Q151N HIV-1
RT proteins. kobs values of wild type
(A) and Q151N (B) proteins were determined at
different dATP concentrations. Higher dATP concentrations were used for
the Q151N protein reactions due to its Kd increase.
The kpol and Kd values were
calculated by fitting these results to Eq. 2 (see "Materials and
Methods").
5 µM
1 s
1
(Table I). In contrast, the Q151N mutant is diminished in its ability
to bind incorrect dGTP a minimum of 14-fold (increase in
Kd), with only a slight increase in its rate of dGTP incorporation (kpol) when compared with wild
type RT. Similar to the case with correct dNTP, the Gln151
residue appears to be involved mainly in the initial binding of RT to
incorrect dNTP, and not in the incorporation
(kpol) of incorrect dNTPs.

View larger version (55K):
[in a new window]
Fig. 3.
Pre-steady state incorporation of incorrect
TTP by wild type and Q151N HIV-1 RT proteins. The
32P-labeled 17-mer primer (S) annealed to the
40-mer RNA template was used in this assay. The T/P (100 nM) bound to RT proteins (700 nM) was
incubated, and the reaction was initiated by the addition of incorrect
TTP (750 µM for wild type and 2.5 mM for
Q151N). Aliquots were taken at different time points (30 s to 10 min),
and the reactions were analyzed by 14% denaturing gel. TTP
incorporation (E) by wild type HIV-1 RT was used to
determine the pre-steady state parameters of wild type RT using
incorrect TTP (Table I).
forward mutation assay, which measures polymerase fidelity under multiple rounds of primer extension, we observe a fidelity change of 12.5 for
the Q151N mutant relative to wild type RT (21). Additionally, single
nucleotide steady state kinetic analyses show that the Q151N mutant is
8-26-fold less efficient at incorporating incorrect dNTP than wild
type RT (22). In other words, pre-steady state kinetic changes in
Kd for the Q151N mutant with incorrect dNTPs appear
to directly affect RT fidelity as determined under steady state
conditions. This finding suggests that initial binding to the incorrect
dNTP is a rate limiting step during mutation synthesis.
5
µM
1 s
1). It is likely that
Q151N is still less efficient at incorporating incorrect dCTP than wild
type. Since this is actually a high end estimate of misincorporation
frequency; however, the reduction in misincorporation of dCTP is
probably less than that seen for dGTP due to the increase in rate of
dCTP incorporation (kpol) by the Q151N mutant.
Binding constants (KD) of wild type and Q151N HIV-1 RT proteins
to three different template-primers
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Asn, there is a significant
decrease in the mutant binding affinity (increase in
Kd) for incorrect dNTPs. As described under
"Results," the Kd values for Q151N with
incorrect dGTP and dCTP are at least 2.5 mM. Since higher
dNTP concentrations actually inhibit DNA polymerization, we can only
make a high end estimate for binding affinity (minimum Kd) to provide a reference point in our discussions
(13). True Kd values are higher than 2.5 mM, meaning that the binding affinity of the Q151N mutant
for incorrect dGTP and dCTP is actually lower than what we describe.
The binding affinity (Kd) for Q151N with TTP could
not be determined because no detectable primer extension was observed
even at high concentrations of TTP and with longer incubation periods
(Fig. 3). It is likely that the Kd value for Q151N
with incorrect TTP is much higher than those of Q151N binding to
incorrect dGTP and dCTP.

View larger version (172K):
[in a new window]
Fig. 4.
Interaction of HIV-1 RT residue 151 with the
incoming dNTP. This figure shows the interaction between
wild type residue Gln151 (light green) or mutant
residue N151 (orange) and the incoming TTP
(black; Ref. 29). This model of HIV-1 RT complexed with a
template (yellow), primer (purple), and incoming
dNTP was generated previously with the programs Molscript (32) and
Raster3D (33) using coordinate set 1rtd.pdb from the Protein Data Bank
(21, 34). Three interactions, shown as dotted black lines,
are depicted: 1) base pairing between the template nucleotide and the
incoming TTP, 2) nonspecific interaction between wild type
Gln151 and the 3'-OH on the sugar moiety of the TTP, and 3)
nonspecific interaction between wild type Gln151 and the
nearby Arg73 (gray) residue. Mutant residue N151
has a shortened R side chain and cannot interact with the sugar on the
incoming TTP. Other residues that make up the HIV-1 RT active site are
drawn in space-filling representation. The finger domain is shown in
dark gray, and the palm domain is present as light
gray space-filling residues.
We recently isolated another high fidelity RT mutant obtained from an
in vivo simian immunodeficiency virus molecular clone (SIVMNE170; Ref. 31). We
found2 that a mutation in
residue 148, Val
Ile, is responsible for the increased fidelity of
this simian immunodeficiency virus RT mutant. Structural examination
reveals that residue Val148 lies near residue
Gln151 on the
8 region of RT. Presumably, the mechanism
by which V148I increases RT fidelity is via disrupting the interaction
between residue Gln151 and the 3'-OH of the incoming dNTP.
In wild type RT, the side chain of residue 148 makes contact with an
opposing peptide backbone between residues 117 and 118. The V148I
mutant, which has a longer side chain than the wild type (Val) residue,
may push the
8 region (including residue Gln151) away
from the RT active site. If V148I modulates the positioning of
Gln151, we can predict that V148I will have altered
enzymatic activity similar to that observed for the Q151N mutant
(i.e. fidelity and incorporation of nucleotide analogs;
Refs. 21 and 22).
Another interesting facet to the Q151N mutant is that at high dNTP
concentrations during both the pre-steady state and steady state, Q151N
is more efficient at incorporating correct nucleotides than wild type
RT (kpol in Table I; kss
in Fig. 1). These results indicate that in wild type RT, the
interaction between residue Gln151 and the incoming dNTP is
inhibitory to the steps of DNA polymerization. One possible explanation
for this is the energetic cost associated with breaking the interaction
between Gln151 and the incoming dNTP. After binding the
dNTP, RT must undergo a conformational change before it catalyzes the
incorporation of the dNTP. During the conformational change from the
open ternary complex to the chemically competent closed complex
(RT·T/P·dNTP
RT*·T/P·dNTP), the interaction between residue
Gln151 and the dNTP may be disrupted. In the Q151N mutant,
there is no energetic cost associated with breaking this nonspecific
interaction. Consequently, the conformational change from an open to a
closed ternary complex is accelerated, resulting in an increase in
kpol. Therefore, despite the fact that residue
Gln151 is essential for error prone DNA synthesis by HIV-1
RT, the presence of Gln151 actually decreases the activity
of wild type RT. It is possible that this reduction in activity is an
expense that wild type HIV-1 RT has to pay to be a highly error prone
DNA polymerase. Because we also observed increases in
kpol for the Q151N mutant when using incorrect
dNTPs (Table I), a disruption in the interaction between residue
Gln151 and the 3'-OH of the incorrect dNTP may also occur
during the conformational change of dNTP misincorporation.
Other studies that employed pre-steady state kinetic analysis to assess HIV-1 RT activity examined the M184V HIV-1 RT mutant, which is a 3TC resistant mutant with a slight increase in fidelity (12). This kinetic study showed that the M184V mutation slightly lowers HIV-1 RT misincorporation efficiency. Due to the fact that the fidelity difference between the mutant and wild type is minimal, it is not clear whether the M184V mutation affects the ability of RT to bind or incorporate incorrect dNTPs. What is unique about the M184V mutation is that it specifically reduces RT binding to 3TCTP, but not to natural dNTPs. The decrease in binding to 3TCTP is what renders the M184V resistant to 3TC. Mutations in the Gln151 residue, which is a residue that interacts with the 3'-OH on the sugar of the incoming dNTP, makes HIV-1 RT resistant to AZTTP (21, 22). Gln151 HIV-1 RT mutants may lose the interaction with the 3' azido group on AZT, and the result is a reduction in RT binding to the incoming AZTTP. Like the evolution of the M184V mutant, it is apparent that HIV-1 RT is able to alter residue Gln151 in such a way that the overall fidelity of the polymerase is not altered, as seen in the low fidelity AZT-resistant Q151M mutant (22).
In summary, the Q151N mutation significantly affects the
Kd of both correct and incorrect dNTPs. These
changes in Kd for Q151N with both correct and
incorrect dNTPs greatly reduce the efficiency at which Q151N
incorporates these nucleotides (kpol/Kd). This suggests that
wild type residue Gln151 promotes RT binding to correct and
incorrect dNTPs, which precedes the incorporation of these nucleotides.
Although we were unable to measure the initial binding affinity of our
Q151N mutant with incorrect dNTPs due to the large increase in
Kd, we can comfortably assume that residue
Gln151 has to be an important molecular element in HIV-1 RT
infidelity. It is also likely that this ability of residue
Gln151 to facilitate the binding of RT to incorrect dNTPs
contributes to the rapid evolution of HIV. Furthermore, it appears that
the interaction between residue Gln151 and correct dNTPs
has a role in efficient DNA synthesis by HIV-1 RT. The relatively large
binding differences between correct and incorrect dNTPs may allow
Gln151 to discriminate against incorrect dNTPs. This
ensures that the DNA polymerase active site is functional and allows
for viral genomic replication. Our study suggests that HIV employs
residue Gln151 to resolve the paradoxical issue of rapid
viral evolution versus efficient viral replication.
| |
FOOTNOTES |
|---|
* This work was supported by Grants GM55500 (to B. K.) and GM29573 (to R. A. B.) and Training Grant AI07362-12 (to K. K. W.) from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Microbiology and Immunology, University of Rochester Medical Center, 601 Elmwood Ave., Box 672, Rochester, NY 14642. Tel.: 585-275-6916; Fax: 585-473-9573; E-mail: baek_kim@urmc.rochester.edu.
Published, JBC Papers in Press, April 1, 2002, DOI 10.1074/jbc.M200202200
2 T. L. Diamond, K. Y. Lee, J. Kimata, and B. Kim, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
dNTP, deoxynucleotide triphosphate;
HIV-1, human immunodeficiency virus
type 1;
RT, reverse transcriptase;
T/P, template/primer;
AZT, azidothymidine;
AZTTP, azidothymidine triphosphate;
3TC, (
)-2',3'-dideoxy-3'-thiacytidine;
3TCTP, (
)-2',3'-dideoxy-3'-thiacytidine triphosphate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Masutani, C., Kusumoto, R., Yamada, A., Dohmae, N., Yokoi, M., Yuasa, M., Araki, M., Iwai, S., Takio, K., and Hanaoka, F. (1999) Nature 399, 700-704[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Friedberg, E. C., and Gerlach, V. L. (1999) Cell 98, 413-416[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Gerlach, V. L.,
Aravind, L.,
Gotway, G.,
Schultz, R. A.,
Koonin, E. V.,
and Friedberg, E. C.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
11922-11927 |
| 4. |
Ohashi, E.,
Bebenek, K.,
Matsuda, T.,
Feaver, W. J.,
Gerlach, V. L.,
Friedberg, E. C.,
Ohmori, H.,
and Kunkel, T. A.
(2000)
J. Biol. Chem.
275,
39678-39684 |
| 5. | Matsuda, T., Bebenek, K., Masutani, C., Hanaoka, F., and Kunkel, T. A. (2000) Nature 404, 1011-1013[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Bebenek, K.,
Matsuda, T.,
Masutani, C.,
Hanaoka, F.,
and Kunkel, T. A.
(2001)
J. Biol. Chem.
276,
2317-2320 |
| 7. | Johnson, K. A. (1993) Annu. Rev. Biochem. 62, 685-713[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Coffin, J. M. (1990) in Virology (Chanock, R. M. , Melnick, J. L. , Monath, T. P. , Roizman, B. , and Straus, S. E., eds) , pp. 1437-1500, Raven, New York |
| 9. |
Preston, B. D.,
Poiesz, B. J.,
and Loeb, L. A.
(1988)
Science
242,
1168-1171 |
| 10. | Williams, K. J., and Loeb, L. A. (1992) Curr. Top. Microbiol. Immunol. 176, 165-180[Medline] [Order article via Infotrieve] |
| 11. | Johnson, K. A. (1995) Methods Enzymol. 249, 38-61[Medline] [Order article via Infotrieve] |
| 12. | Feng, J. Y., and Anderson, K. S. (1999) Biochemistry 38, 9440-9448[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Wong, I., Patel, S. S., and Johnson, K. A. (1991) Biochemistry 30, 526-537[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Carroll, S. S., Cowart, M., and Benkovic, S. J. (1991) Biochemistry 30, 804-813[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Kati, W. M.,
Johnson, K. A.,
Jerva, L. F.,
and Anderson, K. S.
(1992)
J. Biol. Chem.
267,
25988-25997 |
| 16. | Kuchta, R. D., Mizrahi, V., Benkovic, P. A., Johnson, K. A., and Benkovic, S. J. (1987) Biochemistry 26, 8410-8417[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Suzuki, M.,
Avicola, A. K.,
Hood, L.,
and Loeb, L. A.
(1997)
J. Biol. Chem.
272,
11228-11235 |
| 18. |
Suzuki, M.,
Yoshida, S.,
Adman, E. T.,
Blank, A.,
and Loeb, L. A.
(2000)
J. Biol. Chem.
275,
32728-32735 |
| 19. | Li, Y., Korolev, S., and Waksman, G. (1998) EMBO J. 17, 7514-7525[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Li, Y., Korolev, S., and Waksman, G. (1998) Protein Sci. 7, 1116-1123[Abstract] |
| 21. | Weiss, K. K., Isaacs, S. J., Tran, N. H., Adman, E. T., and Kim, B. (2000) Biochemistry 39, 10684-10694[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Kaushik, N., Talele, T. T., Pandey, P. K., Harris, D., Yadav, P. N., and Pandey, V. N. (2000) Biochemistry 39, 2912-2920[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Varatnian, J. P.,
Meyerhans, A.,
Asjo, B.,
and Wainhobson, S.
(1991)
J. Virol.
65,
1779-1789 |
| 24. | Fitzgibbon, J. E., Mazar, S., and Dubin, D. T. (1993) AIDS Res. Hum. Retroviruses. 9, 833-838[Medline] [Order article via Infotrieve] |
| 25. | Kim, B. (1997) Methods 12, 318-324[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Kerr, S. G., and Anderson, K. S. (1997) Biochemistry 36, 14056-14063[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Wong, I.,
and Lohman, T. M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5428-5432 |
| 28. | Suo, Z., and Johnson, K. A. (1997) Biochemistry 36, 12459-12467[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Huang, H.,
Chopra, R.,
Verdine, G. L.,
and Harrison, S. C.
(1998)
Science
282,
1669-1675 |
| 30. | Donlin, M., and Johnson, K. A. (1994) Biochemistry 33, 14908-14917[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Diamond, T. L.,
Kimata, J.,
and Kim, B.
(2001)
J. Biol. Chem.
276,
23624-23631 |
| 32. | Merritt, E. A., and Bacon, D. J. (1997) Methods Enzymol. 277, 505-524[Medline] [Order article via Infotrieve] |
| 33. | Kraulis, P. (1991) J. Appl. Crystallogr. 24, 946-950[CrossRef] |
| 34. | Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Bruce, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., and Tasmui, M. (1977) J. Mol. Biol. 112, 535-542[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
V. K Jamburuthugoda, J. M. Santos-Velazquez, M. Skasko, D. J. Operario, V. Purohit, P. Chugh, E. A. Szymanski, J. E. Wedekind, R. A. Bambara, and B. Kim Reduced dNTP Binding Affinity of 3TC-resistant M184I HIV-1 Reverse Transcriptase Variants Responsible for Viral Infection Failure in Macrophage J. Biol. Chem., April 4, 2008; 283(14): 9206 - 9216. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Howell, C. M. Kondratick, and M. T. Washington Substitution of a residue contacting the triphosphate moiety of the incoming nucleotide increases the fidelity of yeast DNA polymerase {zeta} Nucleic Acids Res., March 1, 2008; 36(5): 1731 - 1740. [Abstract] [Full Text] [PDF] |
||||
|
|